肺动脉高压
医学
内皮
KLF2
内皮功能障碍
肺动脉
下调和上调
基因敲除
内皮干细胞
血管内皮生长因子B
胚胎血管重塑
肺
细胞生物学
血管疾病
发病机制
体内
腺相关病毒
心力衰竭
癌症研究
内科学
基因剔除小鼠
循环系统
内皮细胞活化
条件基因敲除
表型
免疫学
心脏病学
病理
动脉发生
内分泌学
血管
右心室肥大
作者
Qianqian Wang,Jingjing Tian,Dongdong Liu,Tengfei Zheng,X M Liu,Yachao Zhao,Xiao Li,Hongyu Zhong,Jichen Pan,Chong Yuan,Yuliang Zhao,S Wang,Jian Li,Wencheng Zhang,Meng Zhang,Cheng Zhang,Fengming Liu,Mei Zhang,Shen Dai
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2026-06-10
卷期号:154 (8): 750-770
被引量:1
标识
DOI:10.1161/circulationaha.125.066183
摘要
BACKGROUND: Pulmonary hypertension (PH) is a progressive, life-threatening disease characterized primarily by pulmonary vascular remodeling in which endothelial dysfunction plays a vital role. However, the molecular factors contributing to this pathological process remain incompletely understood. Through proteomic analysis of hypoxia-treated human pulmonary artery endothelial cells, we identified serine hydroxymethyltransferase 2 (SHMT2) as a potential target in PH, but its role in disease pathogenesis and the underlying mechanisms remain unclear. METHODS: The expression and function of SHMT2 were assessed in lung samples from patients with PH and in rodent PH models, including hypoxia-exposed mice and monocrotaline- or Sugen 5416/hypoxia–induced rats. Endothelial cell–specific SHMT2 loss and gain of function were achieved by conditional knockout and adeno-associated virus 9–mediated gene modulation. In vitro studies were performed in hypoxia-treated human pulmonary artery endothelial cells and HEK-293T cells. Virtual screening was used to identify a small-molecule inhibitor targeting the nonmetabolic function of SHMT2, and its therapeutic potential was further evaluated in rodent PH models. RESULTS: SHMT2 was upregulated predominantly in pulmonary vascular endothelium of patients with PH and multiple rodent PH models. In vivo, endothelial cell–specific deletion of Shmt2 markedly attenuated pulmonary vascular remodeling and right ventricular dysfunction in PH mice, whereas endothelial cell–specific Shmt2 overexpression aggravated PH development. Consistently, adeno-associated virus 9–mediated endothelial Shmt2 knockdown alleviated PH phenotypes in rat models. Mechanistically, SHMT2 promoted hypoxia-induced endothelial barrier dysfunction mainly through a noncanonical function by blocking the K63-ubiquitin–mediated lysosomal degradation of ras homolog family member B (RhoB). Additional in vivo studies supported an important role of the endothelial SHMT2-RhoB axis in pulmonary vascular remodeling of PH. Through virtual screening, Namodenoson was identified as a small-molecule inhibitor targeting the SHMT2-RhoB pathway. In vivo, Namodenoson showed both preventive and therapeutic effects against PH. CONCLUSIONS: This study highlights endothelial SHMT2 as an important contributor to PH pathogenesis and reveals a noncanonical SHMT2-RhoB pathway that promotes endothelial dysfunction. Targeting this pathway may represent a potential therapeutic strategy for PH.
科研通智能强力驱动
Strongly Powered by AbleSci AI